Anthony McPherson, MD
Interventional Pain Medicine · Marietta, GANPI 1477537660
Payments from drug & device makers
Across 40 payments — averaging $22.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$136
- Abbott$132
- Vertos Medical, Inc.$130
- Medtronic$65
- Amgen$56
- Hikma Pharmaceuticals USA$42
- plus $345 from 14 others
What the payments were for
- Food & beverage$88498%
- Education$212%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 7 | $136 |
| Abbott | 3 | $132 |
| Vertos Medical, Inc. | 4 | $130 |
| Medtronic | 3 | $65 |
| Amgen(2 entities) | 3 | $56 |
| Hikma Pharmaceuticals USA | 2 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $40 |
| Forte Bio-pharma LLC | 1 | $38 |
| Galt Pharmaceuticals, LLC | 1 | $37 |
| Biotronik NRO, Inc. | 2 | $36 |
| Novo Nordisk | 2 | $27 |
| Protega Pharmaceutials Inc | 2 | $26 |
| GE HealthCare | 1 | $23 |
| Masimo Corporation | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Antares Pharma, Inc. | 1 | $18 |
| Kaleo, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Avanos Medical | 1 | $14 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$905 in reported general payments places this provider in the 20th percentile of 129 interventional pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xtampza ErOxycodone Myristate | 62 | $25,802 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 310 | $8,706 |
| Oxycodone Hcl | 370 | $7,837 |
| OxycontinOxycodone Hcl | 17 | $4,987 |
| Naloxone Hcl | 22 | $1,837 |
| Morphine Sulfate ErMorphine Sulfate | 72 | $1,020 |
| Gabapentin | 72 | $847 |
| Tizanidine Hcl | 87 | $827 |
| Fentanyl | 15 | $787 |
| Tramadol Hcl ErTramadol Hcl | 11 | $528 |
| Cyclobenzaprine Hcl | 29 | $456 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 35 | $352 |
| Methadone Hcl | 14 | $249 |
| Methocarbamol | 12 | $116 |
| Amitriptyline Hcl | 23 | $103 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Marietta
- Marvin TarkMarietta$3.6M
- Ali KassamaliMarietta$9K
- David GaleMarietta$8K
- Jordan TateJasper$764K
- Emmanuel GageBrunswick$648K
- Christopher BovinetBrunswick$356K
- D Terrence FosterStockbridge$305K
- David RosenfeldCovington$287K
- Nathan NeufeldNewnan$171K
- Ryan BudwanyLawrenceville$123K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.